Thalidomide plus oral melphalan for advanced multiple myeloma: a phase II study.
Offidani
Massimo
M
Marconi
Monica
M
Corvatta
Laura
L
Olivieri
Attilio
A
Catarini
Massimo
M
Leoni
Pietro
P
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D016879:Salvage Therapy; D016019:Survival Analysis; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000139:chemically induced
D013792:Thalidomide; D008558:Melphalan